Live Breaking News & Updates on Erytech Adss

Stay updated with breaking news from Erytech adss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Erytech Pharma S.A.: ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market

ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market Cambridge, MA (U.S.) and Lyon (France), April 17, 2023 - ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage ....

France General , United States , United Kingdom , Eric Soyer , Pharma Bio , Nicolas Merigeau , Mathilde Bohin Louis Victor Delouvrier , Erytech Adss , Nasdaq Stock Market , Company Securities , Exchange Commission , Company Annual Report On Form , Company Adss , American Depositary Shares , Nasdaq Global Select Market , Nasdaq Capital , Nasdaq Capital Market , Nasdaq Global Select , Capital Market , Nasdaq Listing Agreement , Nasdaq Listing Rule , Next Biotech , French Autorit , Des March , Registration Document , Annual Report ,

Following the Announcement of Its Proposed Merger With Erytech, Pherecydes Pharma Completes a €1.5 Million Capital Increase Reserved to Its Historical Shareholders

This capital increase, fully subscribed by Auriga IV Bioseeds, Ouest Ventures III and the pool of shareholders represented by Guy Rigaud, historical shareholders of Pherecydes Pharma, is part of ....

United States , France General , United Kingdom , South Africa , Erytech Pharma , Dennis Riedl , Pherecydes Pharma , Arthur Rouill , Dusan Oresansky Nicolas Fossiez , European Parliament , Company Board , Financial Services , Board Of Directors The Company , Ouest Ventures , Guy Rigaud , Elaia Partners , Extraordinary General Meeting , French Commercial Code , Capital Increase , New Shares , Euronext Growth , Financial Report , General Meeting , Member States , European Economic Area , Prospectus Regulation ,

Pherecydes Pharma: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies

Conference call and webcast in English on February 16, 2023 at 8:30am EST 02:30pm CET and in French on the same day at 12pm EST 6pm CET Strategic combination would build on complementary expertise ....

United States , France General , South Africa , Gil Beyen , Dennis Riedl , Dusan Oresansky Nicolas Fossiez , Mathilde Bohin Louis Victor Delouvrier , Nicolas Merigeau , Didier Hoch , Enregistrement Universel , Pharma Bio , Pherecydes Pharma , Arthur Rouill , Jean Paul Kress , Eric Soyer , Lyon Commercial Court , Erytech Pharma Inc , Exchange Commission , Strategic Committee , Economic Committee , Nasdaq Euronext , Euronext Growth , Chief Executive Officer , Proposed Merger , Auriga Partners , Auriga Ventures ,

Erytech Pharma S.A.: ERYTECH Announces Receipt of Nasdaq Notice

ERYTECH Announces Receipt of Nasdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 13, 2022 - ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing ....

United States , United Kingdom , France General , New Jersey , Mathilde Bohin Louis Victor Delouvrier , Nicolas Merigeau , Pharma Bio , Eric Soyer , Company American Depositary Shares Adss , Company Adss , Company Securities , Exchange Commission , Company Annual Report On Form , Nasdaq Stock Market , American Depositary Shares , Nasdaq Listing Rule , Notification Letter , Nasdaq Global Select Market , Next Biotech , Private Securities Litigation Reform Act , Nasdaq Listing , French Autorit , Des March , Registration Document , Annual Report , Nasdaq Notice ,

Erytech Pharma S.A.: Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022

Monthly information related to total number of voting rights and shares composing the share capital September 30, 2022. Article 223-16 of general regulation of French Autorité ....

French Autorit , Des March , Global Select Market , Droits De Vote ,